Literature DB >> 25122922

The natural product phyllanthusmin C enhances IFN-γ production by human NK cells through upregulation of TLR-mediated NF-κB signaling.

Youcai Deng1, Jianhong Chu2, Yulin Ren3, Zhijin Fan4, Xiaotian Ji5, Bethany Mundy-Bosse2, Shunzong Yuan6, Tiffany Hughes2, Jianying Zhang7, Baljash Cheema3, Andrew T Camardo2, Yong Xia8, Lai-Chu Wu8, Li-Shu Wang9, Xiaoming He10, A Douglas Kinghorn3, Xiaohui Li11, Michael A Caligiuri12, Jianhua Yu12.   

Abstract

Natural products are a major source for cancer drug development. NK cells are a critical component of innate immunity with the capacity to destroy cancer cells, cancer-initiating cells, and clear viral infections. However, few reports describe a natural product that stimulates NK cell IFN-γ production and unravel a mechanism of action. In this study, through screening, we found that a natural product, phyllanthusmin C (PL-C), alone enhanced IFN-γ production by human NK cells. PL-C also synergized with IL-12, even at the low cytokine concentration of 0.1 ng/ml, and stimulated IFN-γ production in both human CD56(bright) and CD56(dim) NK cell subsets. Mechanistically, TLR1 and/or TLR6 mediated PL-C's activation of the NF-κB p65 subunit that in turn bound to the proximal promoter of IFNG and subsequently resulted in increased IFN-γ production in NK cells. However, IL-12 and IL-15Rs and their related STAT signaling pathways were not responsible for the enhanced IFN-γ secretion by PL-C. PL-C induced little or no T cell IFN-γ production or NK cell cytotoxicity. Collectively, we identify a natural product with the capacity to selectively enhance human NK cell IFN-γ production. Given the role of IFN-γ in immune surveillance, additional studies to understand the role of this natural product in prevention of cancer or infection in select populations are warranted.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122922      PMCID: PMC4162489          DOI: 10.4049/jimmunol.1302600

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

1.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

Review 2.  The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Authors:  Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

Review 3.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 4.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

Review 5.  Acute myeloid leukaemia.

Authors:  Elihu Estey; Hartmut Döhner
Journal:  Lancet       Date:  2006-11-25       Impact factor: 79.321

6.  N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.

Authors:  Kyung-Ho Ha; Mi-Sun Byun; Jin Choi; Jaeho Jeong; Kong-Joo Lee; Dae-Myung Jue
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

7.  The targeted immunocytokine L19-IL2 efficiently inhibits the growth of orthotopic pancreatic cancer.

Authors:  Karola Wagner; Petra Schulz; Arne Scholz; Bertram Wiedenmann; Andreas Menrad
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

8.  IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice.

Authors:  Emma Di Carlo; Alberto Comes; Anna Maria Orengo; Ombretta Rosso; Raffaella Meazza; Piero Musiani; Mario P Colombo; Silvano Ferrini
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

Review 9.  Discovery of new anticancer agents from higher plants.

Authors:  Li Pan; Hee-Byung Chai; Alan Douglas Kinghorn
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

10.  Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.

Authors:  J Chehimi; S E Starr; I Frank; M Rengaraju; S J Jackson; C Llanes; M Kobayashi; B Perussia; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  23 in total

1.  Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis.

Authors:  Elisabetta Vulpis; Francesca Cecere; Rosa Molfetta; Alessandra Soriani; Cinzia Fionda; Giovanna Peruzzi; Giulio Caracciolo; Sara Palchetti; Laura Masuelli; Lucilla Simonelli; Ugo D'Oro; Maria Pia Abruzzese; Maria Teresa Petrucci; Maria Rosaria Ricciardi; Rossella Paolini; Marco Cippitelli; Angela Santoni; Alessandra Zingoni
Journal:  Oncoimmunology       Date:  2017-01-13       Impact factor: 8.110

2.  Potential Anticancer Agents Characterized from Selected Tropical Plants.

Authors:  Yulin Ren; Esperanza J Carcache de Blanco; James R Fuchs; Djaja D Soejarto; Joanna E Burdette; Steven M Swanson; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2019-03-04       Impact factor: 4.050

Review 3.  Discovery of Anticancer Agents of Diverse Natural Origin.

Authors:  A Douglas Kinghorn; Esperanza J Carcache DE Blanco; David M Lucas; H Liva Rakotondraibe; Jimmy Orjala; D Doel Soejarto; Nicholas H Oberlies; Cedric J Pearce; Mansukh C Wani; Brent R Stockwell; Joanna E Burdette; Steven M Swanson; James R Fuchs; Mitchell A Phelps; Lihui Xu; Xiaoli Zhang; Young Yongchun Shen
Journal:  Anticancer Res       Date:  2016-11       Impact factor: 2.480

4.  The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells.

Authors:  Xinxin Li; Wenjuan Dong; Ansel P Nalin; Yufeng Wang; Pan Pan; Bo Xu; Yibo Zhang; Steven Tun; Jianying Zhang; Li-Shu Wang; Xiaoming He; Michael A Caligiuri; Jianhua Yu
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

Review 5.  Modulation of Toll-like receptor signaling in innate immunity by natural products.

Authors:  Luxi Chen; Jianhua Yu
Journal:  Int Immunopharmacol       Date:  2016-02-15       Impact factor: 4.932

6.  Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensis.

Authors:  Yulin Ren; Chunhua Yuan; Youcai Deng; Ragu Kanagasabai; Tran Ngoc Ninh; Vuong Tan Tu; Hee-Byung Chai; Djaja D Soejarto; James R Fuchs; Jack C Yalowich; Jianhua Yu; A Douglas Kinghorn
Journal:  Phytochemistry       Date:  2015-01-14       Impact factor: 4.072

Review 7.  Advances in plant-derived natural products for antitumor immunotherapy.

Authors:  Yi Yang; Qinying Liu; Xianai Shi; Qiuhong Zheng; Li Chen; Yang Sun
Journal:  Arch Pharm Res       Date:  2021-11-09       Impact factor: 4.946

8.  Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function.

Authors:  Youcai Deng; Yann Kerdiles; Jianhong Chu; Shunzong Yuan; Youwei Wang; Xilin Chen; Hsiaoyin Mao; Lingling Zhang; Jianying Zhang; Tiffany Hughes; Yafei Deng; Qi Zhang; Fangjie Wang; Xianghong Zou; Chang-Gong Liu; Aharon G Freud; Xiaohui Li; Michael A Caligiuri; Eric Vivier; Jianhua Yu
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

9.  Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect.

Authors:  Xi Zhou; Li Yu; Min Zhou; Pengfei Hou; Long Yi; Mantian Mi
Journal:  Nutr Metab (Lond)       Date:  2021-06-19       Impact factor: 4.169

10.  Post-Natal Inhibition of NF-κB Activation Prevents Renal Damage Caused by Prenatal LPS Exposure.

Authors:  Wei Guo; Xiao Guan; Xiaodong Pan; Xiongshan Sun; Fangjie Wang; Yan Ji; Pei Huang; Yafei Deng; Qi Zhang; Qi Han; Ping Yi; Michael Namaka; Ya Liu; Youcai Deng; Xiaohui Li
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.